DRUGS FOR DIABETIC NEPHROPATHY- FULL REVIEW
*Dr. Navneet Omprakash Soni
ABSTRACT
The present article highlights the molecules involved in development of diabetic nephropathy and the possible molecular target based on pathophysiological process which can mitigate the development of diabetic complication especially Diabetic nephropathy. In this review article summarizes the available evidence regarding novel drug/agents, Paths and targets under preclinical and clinical trial.
Keywords: ACE, ARB, TGF?, TNF?, VEGF, CTGF, AGEs, RAGE, Oxidative stress.
[Download Article]
[Download Certifiate]